Cancer drug development drives Glenmark’s next phase of global expansion, the company targets USD 600 million revenue from new oncology launches
Childhood leukaemia remains a major health concern across the region. A new study shows India accounts for nearly 70% of South Asia's childhood leukaemia cases.
Pharma regulations continue to shape global healthcare transformation as drug approvals and clinical trials drive safety, innovation, and market expansion
Sugammadex Market in the US is witnessing heightened activity as Lupin steps into this high-value segment. This intensifies complex generics competition and reshapes injectable generics dynamics
The pharmaceutical sector witnessed significant healthcare developments this month, spanning regulatory reforms, manufacturing expansion, drug innovation, and public health.
The Ebola outbreak in the Democratic Republic of Congo has become the second-largest on record globally
The API Surge helped Strong Q1 Performance at RPG Life Sciences during the first quarter of FY27. The company reported healthy revenue growth, stronger domestic formulations, and resumed API operations. It also announced a major restructuring plan...
Strong Business, Indegene, Q1 FY27, operating revenue, net profit, EBITDA, EBITDA margin, active clients, Gen AI, pharmaceutical services, healthcare technology, revenue growth
MedTech Hub development in India accelerates as a new policy framework and global partnerships reshape the country’s medical technology sector
Innovative expansion and drug regulation continue to reshape India’s pharmaceutical sector. The latest updates signify a strong push toward technology-driven research
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")